Tag Archive for: COVID-19 vaccination

Pfizer-BioNTech COVID-19 Vaccine for Ages 5 to 11 Years

BioNTech COVID-19 vaccine for ages 5 to 11 years – To jab or not to jab?

COVID-19 vaccines have been approved for use early in 2021, with the BioNTech mRNA vaccine (Comirnaty®) being one of the first vaccines made widely available in the market. The BNT162b2 vaccine, which carries a nucleoside-modified messenger RNA encoding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein, produces a high serum neutralising antibody titre and antigen-specific T-cell response when administered in two 30µg doses in healthy adults.

Safety and Immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in Patients after Allogeneic HCT or CD19-based CAR-T therapy

Safety and Immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in Patients after Allogeneic HCT or CD19-based CAR-T therapy

In this single centre prospective cohort study, the efficacy and toxicity of BNT162b2 vaccine were evaluated in patients who underwent haematopoietic cell transplantation (HCT) and chimeric antigen receptor T-cell (CAR-T) therapy